Methods and compositions using FGF23 fusion polypeptides

Details for Australian Patent Application No. 2011209380 (hide)

Owner Novartis AG

Inventors Glass, David; Hu, Shou-Ih

Agent Davies Collison Cave

Pub. Number AU-A-2011209380

PCT Pub. Number WO2011/092234

Priority 12/696,693 29.01.10 US

Filing date 27 January 2011

Wipo publication date 4 August 2011

International Classifications

C12N 15/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

G01N 33/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

G01N 33/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

9 August 2012 PCT application entered the National Phase

  PCT publication WO2011/092234 Priority application(s): WO2011/092234

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011209381-Wind power plant and wind power plant tower segment

2011209378-Derivatives of diphosphines as flame retardants for polyurethanes